Liu Peng, Lee Sooyeon, Knoll Jeanette, Rauch Alexander, Ostermay Susanne, Luther Julia, Malkusch Nicole, Lerner Ulf H, Zaiss Mario M, Neven Mona, Wittig Rainer, Rauner Martina, David Jean-Pierre, Bertolino Philippe, Zhang Chang X, Tuckermann Jan P
Institute of Comparative Molecular Endocrinology, University of Ulm, Ulm D-89081, Germany.
Tissue-specific Hormone Action, Leibniz Institute on Aging-Fritz Lipmann Institute (FLI), Jena D-07745, Germany.
Cell Death Differ. 2017 Apr;24(4):672-682. doi: 10.1038/cdd.2016.165. Epub 2017 Jan 20.
During osteoporosis bone formation by osteoblasts is reduced and/or bone resorption by osteoclasts is enhanced. Currently, only a few factors have been identified in the regulation of bone integrity by osteoblast-derived osteocytes. In this study, we show that specific disruption of menin, encoded by multiple endocrine neoplasia type 1 (Men1), in osteoblasts and osteocytes caused osteoporosis despite the preservation of osteoblast differentiation and the bone formation rate. Instead, an increase in osteoclast numbers and bone resorption was detected that persisted even when the deletion of Men1 was restricted to osteocytes. We demonstrate that isolated Men1-deficient osteocytes expressed numerous soluble mediators, such as C-X-C motif chemokine 10 (CXCL10), and that CXCL10-mediated osteoclastogenesis was reduced by CXCL10-neutralizing antibodies. Collectively, our data reveal a novel role for Men1 in osteocyte-osteoclast crosstalk by controlling osteoclastogenesis through the action of soluble factors. A role for Men1 in maintaining bone integrity and thereby preventing osteoporosis is proposed.
在骨质疏松症中,成骨细胞的骨形成减少和/或破骨细胞的骨吸收增强。目前,在由成骨细胞衍生的骨细胞对骨完整性的调节中,仅鉴定出少数几个因子。在本研究中,我们表明,尽管成骨细胞分化和骨形成率得以保留,但在成骨细胞和骨细胞中由多发性内分泌肿瘤1型(Men1)编码的Menin特异性破坏仍导致骨质疏松症。相反,检测到破骨细胞数量增加和骨吸收增加,即使Men1的缺失仅限于骨细胞,这种情况仍持续存在。我们证明,分离出的缺乏Men1的骨细胞表达多种可溶性介质,如C-X-C基序趋化因子10(CXCL10),并且CXCL10中和抗体可减少CXCL10介导的破骨细胞生成。总体而言,我们的数据揭示了Men1在骨细胞-破骨细胞串扰中的新作用,即通过可溶性因子的作用控制破骨细胞生成。我们提出了Men1在维持骨完整性从而预防骨质疏松症中的作用。